MedPath

Sleep Intervention to Improve Glycemic Control in Women With Gestational Diabetes

Not Applicable
Completed
Conditions
Gestational Diabetes Mellitus in Pregnancy
Interventions
Behavioral: Sleep Education for Pregnancy
Registration Number
NCT03266133
Lead Sponsor
University of Pittsburgh
Brief Summary

This is a pilot randomized controlled trial involving a sleep education intervention in women with gestational diabetes to study whether sleep education during pregnancy leads to improvement in glycemic control in women with gestational diabetes and improvement in sleep duration.

Detailed Description

Patients will be identified from the Maternal-Fetal Medicine office and the Perinatal Assessment Clinic at Magee-Womens Hospital, University of Pittsburgh Medical Center. Patients with gestational diabetes will be recruited following general education regarding gestational diabetes in pregnancy which is universally done for all patients at the time of their diagnosis of gestational diabetes. Eligible subjects will be randomized to two groups (usual care vs. sleep education program).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
74
Inclusion Criteria
  1. Pregnant female
  2. Ages 18-50
  3. Gestational age between 16 0/7 weeks and 31 6/7 weeks
  4. New diagnosis of GDM, not on treatment (i.e., insulin, glyburide, or metformin) at the time of enrollment
Exclusion Criteria
  1. Children less than 18 years of age
  2. Non-English speaking
  3. Multiple gestations (twins, triplets, etc)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sleep Education InterventionSleep Education for PregnancyThis is a two-session program designed to educate patients about healthy sleep in respect to timing, regularity, efficiency, and duration in order to promote sleep during pregnancy.
Primary Outcome Measures
NameTimeMethod
Glycemic control3-6 months during pregnancy

Proportion of participants achieving glycemic control at study end. Glycemic control defined as greater than 75% of weeks with average fasting blood glucose \< 95 mg/dL and 1-hr postprandial blood glucose \<140 mg/dL.

Self-reported sleep duration3-6 months during pregnancy

Proportion of patients who report sleeping between 7-9 hours per night

Secondary Outcome Measures
NameTimeMethod
Gestational age at deliveryTime of delivery
Average fasting glucose values3-6 months during pregnancy
Average postprandial glucose values3-6 months during pregnancy
Indication for deliveryTime of delivery

Medical records will be used to determine whether a patient when into spontaneous labor, had an induction or labor or a recommended delivery by cesarean section. If the patient had an induction or labor or a recommended cesarean delivery, the indication for this recommendation will be recorded.

Neonatal birth weightTime of delivery
Route of deliveryTime of delivery

Medical records will be reviewed to determine if the patient had a vaginal delivery or cesarean delivery.

PreeclampsiaTime of delivery

Medical records will be reviewed to determine whether a patient had a diagnosis of preeclampsia prior to delivery.

Trial Locations

Locations (1)

Magee-Womens Hospital of UPMC

🇺🇸

Pittsburgh, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath